Your Navigation:PCAR > Abstract
Search pcar
Pharmaceutical Care and Research: 2018; 18(2):81-86
DOI: 10.5428/pcar20180201
Research advances in nanoformulations of docetaxel
1. XU YouFa1(1.Teaching Office of Pharmaceutics,School of Pharmacy,Fujian University of Traditional Chinese Medicine,Fuzhou 350122,China
2. 2(2.Teaching Office of Pharmaceutics,School of Pharmacy,Second Military Medical University,Shanghai 200433,China
3. CHENG Dan2(2.Teaching Office of Pharmaceutics,School of Pharmacy,Second Military Medical University,Shanghai 200433,China )
4. FU ZhiQin1(1.Teaching Office of Pharmaceutics,School of Pharmacy,Fujian University of Traditional Chinese Medicine,Fuzhou 350122,China )
5. CHEN JianMing1(1.Teaching Office of Pharmaceutics,School of Pharmacy,Fujian University of Traditional Chinese Medicine,Fuzhou 350122,China
6. 2(2.Teaching Office of Pharmaceutics,School of Pharmacy,Second Military Medical University,Shanghai 200433,China
ABSTRACT  Docetaxel,one of the taxoid antitumor drugs,has good clinical effects on many kinds of cancer.However,due to the side effects caused by docetaxel itself and its solvent,its application is seriously restricted clinically.As nanoformulations have shown good perspective in terms of sustained drug release,prolonged drug efficacy,reduced toxicity and improved bioavailability of insoluble drugs,they are now a hot research topic both at home and abroad.This paper gives a comprehensive review on the current literature of nanoformulations of docetaxel as well as a perspective on future development and application,so as to provide reference for the research and development of new nanoformulations of docetaxel.
Welcome to PCAR! You are the number 65 reader of this article!
Please cite this article as:
XU YouFa1,2,CHENG Dan2,FU ZhiQin1,CHEN JianMing1,2,. Research advances in nanoformulations of docetaxel[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(2): 81-86.
1. Rowinsky E K.The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents[J].Annu Rev Med,1997,48(48):353-374.
2. Jones S.Head-to-head:docetaxel challenges paclitaxel[J].EJC Suppl,2006,4(4):4-8.
3. Lee W H,Loo C Y,Young P M,et al.Recent advances in curcumin nanoformulation for cancer therapy[J].Expert Opin Drug Deliv,2014,11(8):1183-1201.
4. LI YingHuan,ZHENG XueLian,SUN Yi,et al.RGD-fatty alcohol-modified docetaxel liposomes improve tumor selectivity in vivo[J].Int J Pharm,2014,468(1-2):133-141.
5. CHANG MingLu,LU ShanShan,ZHANG Fang,et al.RGD-modified pH-sensitive liposomes for docetaxel tumor targeting[J].Colloids Surf B Biointerfaces,2015,129(3):175-182.
6. ZUO TianTian,GUAN YuanYuan,CHANG MingLu,et al.RGD (Arg-Gly-Asp) internalized docetaxel-loaded pH sensitive liposomes:preparation,characterization and antitumor efficacy in vivo and in vitro[J].Colloids Surf B Biointerfaces,2016,147(7):90-99.
7. Muthu M S,Kulkarni S A,Raju A,et al.Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots[J].Biomaterials,2012,33(12):3494-3501.
8. JI ZhuWa,QIN FuHua,XIA XiaoJing,et al.Study on targeting of folic acid-modified docetaxel nano-liposome to hepatocellular carcinoma Bel-7402 cells in vivo and in vitro[J].China Pharmacy,2016,27(10):1325-1328.In Chinese with English abstract.
9. Ranjan A,Benjamin C J,Negussie A H,et al.Biodistribution and efficacy of low temperature-sensitive liposome encapsulated docetaxel combined with mild hyperthermia in a mouse model of prostate cancer[J].Pharm Res,2016,33(10):1-11.
10. JIN MingJi,PIAO ShengJun,JIN TieXiong,et al.Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles[J].J Huazhong Univ Sci Technol(Med Sci),2014,34(1):66-75.
11. LI YunFei,JIN MingJi,SHAO Shuai,et al.Small-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer model[J].BMC Cancer,2014,14(1):329-341.
12. Singh R P,Sharma G,Poornima S,et al.Transferrin receptor targeted PLA-TPGS micelles improved efficacy and safety in docetaxel delivery[J].Int J Biol Macromol,2016.DOI:10.1016/j.ijbiomac.2015.11.081.
13. Sonali,Agrawal P,Singh R P,et al.Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy:preparation,characterization and brain distribution in rats[J].Drug Deliv,2016,23(5):1788-1798.
14. SHI ChunHuan,ZHANG ZhiQing,SHI JiaXing,et al.Co-delivery of docetaxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance[J].Int J Pharm,2015,495(2):932-939.
15. YU Yang,QIU LiYan.Optimizing particle size of docetaxel-loaded micelles for enhanced treatment of oral epidermoid carcinoma[J].Nanomed Nanotechnol Biol Med,2016,12(7):1941-1949.
16. Kutty R V,Chia S L,Setyawati M I,et al.In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer[J].Biomaterials,2015,63(1):58-69.
17. SU ZhiHui,LIANG YanChao,YAO Yao,et al.Polymeric complex micelles based on the double-hydrazone linkage and dual drug-loading strategy for pH-sensitive docetaxel delivery[J].J Mater Chem B,2016,4(6):1122-1133.
18. SHI ChunHuan,ZHANG ZhiQing,WANG Fang,et al.Docetaxel-loaded PEO-PPO-PCL/TPGS mixed micelles for overcoming multidrug resistance and enhancing antitumor efficacy[J].J Mater Chem B,2015,3(20):4259-4271.
19. WANG Lu,XIE Xie,LIU Di,et al.iRGD-mediated reduction-responsive DSPE-PEG/LA-PLGA-TPGS mixed micelles used in the targeted delivery and triggered release of docetaxel in cancer[J].RSC Adv,2016,6(34):28331-28342.
20. YANG Nan,JIANG Yao,ZHANG HuiFeng,et al.Active targeting docetaxel-PLA nanoparticles eradicate the circulating lung cancer stem like cells and inhibit the liver metastasis[J].Mol Pharm,2015,12(1):232-239.
21. Pawar H,Wankhade S R,Yadav D K,et al.Development and evaluation of co-formulated docetaxel and curcumin biodegradable nanoparticles for parenteral administration[J].Pharm Dev Technol,2015,21(6):725-736.
22. HU LianDong,PANG SaiXi,HU QiaoFeng,et al.Enhanced antitumor efficacy of folate targeted nanoparticles co-loaded with docetaxel and curcumin[J].Biomed Pharmacother,2015,75:26-32.
23. Jain A,Thakur K,Kush P,et al.Docetaxel loaded chitosan nanoparticles:formulation,characterization and cytotoxicity studies[J].Int J Biol Macromol,2014,69(8):546-553.
24. Jain A,Thakur K,Sharma G,et al.Fabrication,characterization and cytotoxicity studies of ionically cross-linked docetaxel loaded chitosan nanoparticles[J].Carbohydr Polymers,2015,137:65-74.
25. JIANG ShouGang,GONG XianFeng,ZHAO XiuHua,et al.Preparation,characterization,and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles[J].Drug Deliv,2015,22(2):206-213.
26. Roy A,Murakami M,Ernsting M J,et al.Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance[J].Mol Pharm,2014,11(8):2592-2599.
27. Jain S,Spandana G,Agrawal A K,et al.Enhanced antitumor efficacy and reduced toxicity of docetaxel loaded estradiol functionalized stealth polymeric nanoparticles[J].Mol Pharm,2015,12(11):3871-3884.
28. Chen F,Zhang J,Wang L,et al.Tumor pH(e)-triggered charge-reversal and redox-responsive nanoparticles for docetaxel delivery in hepatocellular carcinoma treatment[J].Nanoscale,2015,7(38):15763-15779.
29. Oh K S,Han H,Yoon B D,et al.Effect of HIFU treatment on tumor targeting efficacy of docetaxel-loaded pluronic nanoparticles[J].Colloids Surf B Biointerfaces,2014,119(1):137-144.
30. Naguib Y W,Rodriguez B L,LI XinRan,et al.Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides:in vitro and in vivo evaluation[J].Mol Pharm,2014,11(4):1239-1249.
31. YUAN Qing,HAN Jing,CONG WenShu,et al.Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity[J].Int J Nanomed,2014,9:4829-4846.
32. Lee S E,Lee J K,Jang W S,et al.Enhancement of stability and controlled drug release of lipid nanoparticles by modified solvent-evaporation method[J].Colloids Surf A Physicochem Eng Aspects,2016,508(2):294-300.
33. Fang G,Tang B,Chao Y,et al.Improved oral bioavailability of docetaxel by nanostructured lipid carriers:in vitro characteristics,in vivo evaluation and intestinal transport studies[J].Rsc Advances,2015,5(117):96437-96447.
34. JIANG WeiHua,WANG Ju,YANG Lei,et al.Nanostructured lipid carriers modified with PEGylated carboxymethylcellulose polymers for effective delivery of docetaxel[J].Rsc Adv,2015,5(110):90386-90395.
35. MENG JiaNing,Agrahari V,Youm I.Advances in targeted drug delivery approaches for the central nervous system tumors:the inspiration of nanobiotechnology[J].J Neuroimmune Pharmacol,2016,14(1):1-15.
36. Alibolandi M,Abnous K,Hadizadeh F,et al.Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo[J].J Control Release,2016,241:45-56.
37. LIU HeLong,HU KaiLi,FENG JianFang.Development and characterization of TPGS modified proniosomes of docetaxel[J].China J Chin Mat Med,2015,40(19):3775-3779.In Chinese with English abstract.
38. ZENG XiaoWei,TAO Wei,WANG ZhongYuan,et al.Docetaxel-loaded nanoparticles of dendritic amphiphilic block copolymer H40-PLA-b-TPGS for cancer treatment[J].Part Part Syst Charact,2015,32(1):112-122.
39. ZHOU XiaoYan,ZHENG QianQian,WANG ChangYong,et al.Star-shaped amphiphilic hyperbranched polyglycerol conjugated with dendritic poly(L-lysine) for the codelivery of docetaxel and MMP-9 siRNA in cancer therapy[J].Acs Appl Mater Interfaces,2016,8(20):12609-12619.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330